Shahbaz Amir, Senapathi Sri Harshavardhan, Aziz Kashif, Umair Muhammad, Khalid Amna, Sachmechi Issac
Internal Medicine, Icahn School of Medicine at Mount Sinai/Queens Hospital Center, New York, USA.
Medicine, Queens Hospital Center, Jamaica, USA.
Cureus. 2018 Aug 27;10(8):e3209. doi: 10.7759/cureus.3209.
There is an increased association between chronic urticaria (CU) and thyroid autoantibodies. We presented a case of a patient suffering from CU and newly diagnosed Hashimoto's thyroiditis in which levothyroxine therapy completely resolved the symptoms of urticaria. A 58-year-old female with a past medical history of recurrent urticaria presented with complaints of fatigue and weight gain. Laboratory investigations showed a high thyroid stimulating hormone (TSH) level and a low free thyroxine (T4) level. She had elevated levels of antithyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies (anti-TG). She was diagnosed as a case of Hashimoto's thyroiditis and started on levothyroxine therapy. She noticed that her uncontrolled recurrent urticaria started to get better and after a few months of therapy, she stopped taking her topical ointments and antihistamines. The reason for the association between positive serological tests for thyroid autoimmunity and CU is unclear. The resolution of chronic urticaria with levothyroxine in our patient with Hashimoto's thyroiditis suggests a common underlying mechanism between the two pathologies.
慢性荨麻疹(CU)与甲状腺自身抗体之间的关联日益增加。我们报告了一例患有CU且新诊断为桥本甲状腺炎的患者,其中左甲状腺素治疗完全缓解了荨麻疹症状。一名有复发性荨麻疹病史的58岁女性,出现疲劳和体重增加的症状。实验室检查显示促甲状腺激素(TSH)水平升高,游离甲状腺素(T4)水平降低。她的抗甲状腺过氧化物酶(抗-TPO)和抗甲状腺球蛋白抗体(抗-TG)水平升高。她被诊断为桥本甲状腺炎,并开始接受左甲状腺素治疗。她注意到她无法控制的复发性荨麻疹开始好转,经过几个月的治疗,她停止使用外用软膏和抗组胺药。甲状腺自身免疫血清学检测呈阳性与CU之间关联的原因尚不清楚。在我们这位患有桥本甲状腺炎的患者中,左甲状腺素使慢性荨麻疹得到缓解,这表明两种疾病之间存在共同的潜在机制。